The Delhi High Court has expressed concern over the misuse of diabetes drugs like Ozempic for weight loss, directing the Central Drugs Standard Control Organisation to respond in three months. The petition highlights dangerous promotions and potential health risks associated with these medications being used without medical supervision.
